Treatment of Delayed Cerebral Ischemia in Good-Grade Subarachnoid Hemorrhage: Any Role for Invasive Neuromonitoring?

Brain tissue oxygen Cerebral microdialysis Delayed cerebral ischemia Invasive neuromonitoring Subarachnoid hemorrhage

Journal

Neurocritical care
ISSN: 1556-0961
Titre abrégé: Neurocrit Care
Pays: United States
ID NLM: 101156086

Informations de publication

Date de publication:
08 2021
Historique:
received: 29 06 2020
accepted: 24 11 2020
pubmed: 12 12 2020
medline: 30 9 2021
entrez: 11 12 2020
Statut: ppublish

Résumé

Good-grade aneurysmal subarachnoid hemorrhage (Hunt and Hess 1-2) is generally associated with a favorable prognosis. Nonetheless, patients may still experience secondary deterioration due to delayed cerebral ischemia (DCI), contributing to poor outcome. In those patients, neurological assessment is challenging and invasive neuromonitoring (INM) may help guide DCI treatment. An observational analysis of 135 good-grade SAH patients referred to a single tertiary care center between 2010 and 2018 was performed. In total, 54 good-grade SAH patients with secondary deterioration evading further neurological assessment, were prospectively enrolled for this analysis. The cohort was separated into two groups: before and after introduction of INM in 2014 (pre-INM Secondary deterioration, impeding neurological assessment, occurred in 54 (40.0%) of all good-grade SAH patients. In those patients, a comparable rate of favorable outcome at 12 months was observed before and after the introduction of INM (pre-INM A considerable number of patients with good-grade SAH experiences secondary deterioration rendering them neurologically not assessable. In our cohort, the introduction of INM to guide DCI treatment in patients with secondary deterioration increased the rate of good recovery after 12 months. Additionally, a significant reduction of CT scans and infarction load was recorded, which may have an underestimated impact on quality of life and more subtle neuropsychological deficits common after SAH.

Sections du résumé

BACKGROUND
Good-grade aneurysmal subarachnoid hemorrhage (Hunt and Hess 1-2) is generally associated with a favorable prognosis. Nonetheless, patients may still experience secondary deterioration due to delayed cerebral ischemia (DCI), contributing to poor outcome. In those patients, neurological assessment is challenging and invasive neuromonitoring (INM) may help guide DCI treatment.
METHODS
An observational analysis of 135 good-grade SAH patients referred to a single tertiary care center between 2010 and 2018 was performed. In total, 54 good-grade SAH patients with secondary deterioration evading further neurological assessment, were prospectively enrolled for this analysis. The cohort was separated into two groups: before and after introduction of INM in 2014 (pre-INM
RESULTS
Secondary deterioration, impeding neurological assessment, occurred in 54 (40.0%) of all good-grade SAH patients. In those patients, a comparable rate of favorable outcome at 12 months was observed before and after the introduction of INM (pre-INM
CONCLUSIONS
A considerable number of patients with good-grade SAH experiences secondary deterioration rendering them neurologically not assessable. In our cohort, the introduction of INM to guide DCI treatment in patients with secondary deterioration increased the rate of good recovery after 12 months. Additionally, a significant reduction of CT scans and infarction load was recorded, which may have an underestimated impact on quality of life and more subtle neuropsychological deficits common after SAH.

Identifiants

pubmed: 33305337
doi: 10.1007/s12028-020-01169-x
pii: 10.1007/s12028-020-01169-x
pmc: PMC8285339
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

172-183

Informations de copyright

© 2020. The Author(s).

Références

de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ. Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry. 2007;78:1365–72.
doi: 10.1136/jnnp.2007.117655
van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369:306–18.
doi: 10.1016/S0140-6736(07)60153-6
Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol. 2011;10:349–56.
doi: 10.1016/S1474-4422(11)70017-5
Rabinstein AA, Friedman JA, Weigand SD, et al. Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke. 2004;35:1862–6.
doi: 10.1161/01.STR.0000133132.76983.8e
Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke. 2007;38:1831–6.
doi: 10.1161/STROKEAHA.106.477976
Anzabi M, Angleys H, Aamand R, et al. Capillary flow disturbances after experimental subarachnoid hemorrhage: a contributor to delayed cerebral ischemia? Microcirculation 2018: 12516.
Liu H, Dienel A, Scholler K, et al. Microvasospasms after experimental subarachnoid hemorrhage do not depend on endothelin A receptors. Stroke. 2018;49:693–9.
doi: 10.1161/STROKEAHA.117.020028
Balbi M, Koide M, Wellman GC, Plesnila N. Inversion of neurovascular coupling after subarachnoid hemorrhage in vivo. J Cereb Blood Flow Metab. 2017;37:3625–34.
doi: 10.1177/0271678X16686595
Terpolilli NA, Brem C, Buhler D, Plesnila N. Are we barking up the wrong vessels? Cerebral microcirculation after subarachnoid hemorrhage. Stroke. 2015;46:3014–9.
doi: 10.1161/STROKEAHA.115.006353
Report of World Federation of Neurological Surgeons Committee on a Universal Subarachnoid Hemorrhage Grading Scale. J Neurosurg 1988;68:985–6.
Hunt WE, Hess RM. Surgical risk as related to time of intervention in the repair of intracranial aneurysms. J Neurosurg. 1968;28:14–20.
doi: 10.3171/jns.1968.28.1.0014
van der Steen WE, Leemans EL, van den Berg R, et al. Radiological scales predicting delayed cerebral ischemia in subarachnoid hemorrhage: systematic review and meta-analysis. Neuroradiology. 2019;61:247–56.
doi: 10.1007/s00234-019-02161-9
van Donkelaar CE, Bakker NA, Veeger NJ, et al. Prediction of outcome after subarachnoid hemorrhage: timing of clinical assessment. J Neurosurg. 2017;126:52–9.
doi: 10.3171/2016.1.JNS152136
Galea JP, Dulhanty L, Patel HC. Predictors of outcome in aneurysmal subarachnoid hemorrhage patients: observations from a multicenter data set. Stroke. 2017;48:2958–63.
doi: 10.1161/STROKEAHA.117.017777
Helbok R, Kurtz P, Vibbert M, et al. Early neurological deterioration after subarachnoid haemorrhage: risk factors and impact on outcome. J Neurol Neurosurg Psychiatry. 2013;84:266–70.
doi: 10.1136/jnnp-2012-302804
Vergouwen MD, Vermeulen M, van Gijn J, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41:2391–5.
doi: 10.1161/STROKEAHA.110.589275
Albanna W, Weiss M, Muller M, et al. Endovascular rescue therapies for refractory vasospasm after subarachnoid hemorrhage: a prospective evaluation study using multimodal. Contin Event Neuromonit Neurosurg. 2017;80:942–9.
Weiss M, Conzen C, Mueller M, et al. Endovascular rescue treatment for delayed cerebral ischemia after subarachnoid hemorrhage is safe and effective. Front Neurol. 2019;10:136.
doi: 10.3389/fneur.2019.00136
Veldeman M, Albanna W, Weiss M, et al. Invasive neuromonitoring with an extended definition of delayed cerebral ischemia is associated with improved outcome after poor-grade subarachnoid hemorrhage. J Neurosurg 2020:1–8.
Kuchler J, Tronnier F, Smith E, Gliemroth J, Tronnier VM, Ditz C. The impact of intrahospital transports on brain tissue metabolism in patients with acute brain injury. Neurocrit Care. 2019;30:216–23.
doi: 10.1007/s12028-018-0604-y
Degen LA, Dorhout Mees SM, Algra A, Rinkel GJ. Interobserver variability of grading scales for aneurysmal subarachnoid hemorrhage. Stroke. 2011;42:1546–9.
doi: 10.1161/STROKEAHA.110.601211
Maloney-Wilensky E, Gracias V, Itkin A, Hoffman K, et al. Brain tissue oxygen and outcome after severe traumatic brain injury: a systematic review. Crit Care Med. 2009;37:2057–63.
doi: 10.1097/CCM.0b013e3181a009f8
Hutchinson PJ, Jalloh I, Helmy A, Carpenter KL, et al. Consensus statement from the 2014 International Microdialysis Forum. Intensive Care Med. 2015;41:1517–28.
doi: 10.1007/s00134-015-3930-y
Jennett B, Snoek J, Bond MR, Brooks N. Disability after severe head injury: observations on the use of the Glasgow Outcome Scale. J Neurol Neurosurg Psychiatry. 1981;44:285–93.
doi: 10.1136/jnnp.44.4.285
Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15:573–85.
doi: 10.1089/neu.1998.15.573
Zheng K, Zhong M, Zhao B, et al. Poor-grade aneurysmal subarachnoid hemorrhage: risk factors affecting clinical outcomes in intracranial aneurysm patients in a multi-center study. Front Neurol. 2019;10:123.
doi: 10.3389/fneur.2019.00123
Buunk AM, Spikman JM, Metzemaekers JDM, van Dijk JMC, Groen RJM. Return to work after subarachnoid hemorrhage: the influence of cognitive deficits. PLoS ONE. 2019;14:e0220972.
doi: 10.1371/journal.pone.0220972
Stienen MN, Smoll NR, Weisshaupt R, et al. Delayed cerebral ischemia predicts neurocognitive impairment following aneurysmal subarachnoid hemorrhage. World Neurosurg. 2014;82:e599–605.
doi: 10.1016/j.wneu.2014.05.011
de Oliveira Manoel AL, Jaja BN, Germans MR, et al. The VASOGRADE: a simple grading scale for prediction of delayed cerebral ischemia after subarachnoid hemorrhage. Stroke. 2015;46:1826–31.
doi: 10.1161/STROKEAHA.115.008728
Leira EC, Davis PH, Martin CO, et al. Improving prediction of outcome in “good grade” subarachnoid hemorrhage. Neurosurgery. 2007;61:470–3 discussion 3-4.
doi: 10.1227/01.NEU.0000290891.39330.05
Ulrich CT, Fung C, Vatter H, et al. Occurrence of vasospasm and infarction in relation to a focal monitoring sensor in patients after SAH: placing a bet when placing a probe? PLoS ONE. 2013;8:e62754.
doi: 10.1371/journal.pone.0062754

Auteurs

Michael Veldeman (M)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany. mveldeman@ukaachen.de.
Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, The Netherlands. mveldeman@ukaachen.de.

Walid Albanna (W)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Miriam Weiss (M)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Catharina Conzen (C)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Tobias Philip Schmidt (TP)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Hans Clusmann (H)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Henna Schulze-Steinen (H)

Department of Intensive Care Medicine, RWTH Aachen University, Aachen, Germany.

Omid Nikoubashman (O)

Department of Diagnostic and Interventional Neuroradiology, RWTH Aachen University, Aachen, Germany.

Yasin Temel (Y)

Department of Neurosurgery, Maastricht University Medical Centre, Maastricht, The Netherlands.

Gerrit Alexander Schubert (GA)

Department of Neurosurgery, RWTH Aachen University Hospital, Pauwelsstrasse 30, 52074, Aachen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH